BIS

Fund Description
ProShares UltraShort Nasdaq Biotechnology seeks daily investment results before fees and expenses that correspond to twice (200%) the inverse (opposite) of the daily performance of the NASDAQ Biotechnology Index.
Fund Profile
Fund Name ProShares UltraShort Nasdaq Biotechnology
Fund Exchange Ticker BIS
Fund Sponsor ProShares
Fund ISIN US74347G8380
Net Expense Ratio 0.95 %
Fund Inception Date 7 April 2010
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific Leveraged / Inverse
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Nasdaq Biotech Index
Index Provider Nasdaq
Currency Hedged No
Inverse / Leveraged Inverse (-2x)
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 28 October 2020
Asset Under Management 14.23 Million (USD)
1 Month Total Return 1.40 %
Year To Date Return -40.52 %
1 Year Total Return -53.18 %
3 Year Annualized Total Return -29.34 %
NAV 31.8902
Share Outstanding 446,100
Top 10 Holdings (27 October 2020)
Constituent Name Constituent Ticker Constituent Type Weighting
NASDAQ Biotechnology Index SWAP Bank of America NA SWAP
NASDAQ Biotechnology Index SWAP Societe Generale SWAP
iShares Biotech (IBB) SWAP Morgan Stanley & Co. International PLC SWAP
NASDAQ Biotechnology Index SWAP Credit Suisse International SWAP
NASDAQ Biotechnology Index SWAP Citibank NA SWAP
iShares Biotech (IBB) SWAP Bank of America NA SWAP
NASDAQ Biotechnology Index SWAP Morgan Stanley & Co. International PLC SWAP
Net Other Assets / Cash CASH
NASDAQ Biotechnology Index SWAP UBS AG SWAP